Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Benitec Biopharm Ads (NASDAQ: BNTC)

$2.64 USD -$0.01 (-0.38%)
Last Price $2.64
Net Change $-0.01 (-0.38%)
Bid $2.2
Ask Price $4
Open Price $2.78
Previous Close Price $2.65
High Price $2.8
Low Price $2.64
Number of Trades 197
Volume 51,999
Fifty Two Week High $5.48 (2017-04-04)
Fifty Two Week Low $1.2 (2016-07-06)
Average Daily Volume 754,674
Share Outstanding 10,260 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-0.28
Last Quarter EPS $
Market Capitalization $0.03B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 10,260
Inst. Shareholder % 2.64%
Annual Net Income $0B
TTM Net Profit Margin $100.03
1-Year Return 76.67%
3-Year Return -88.58%
5-Year Return -88.58%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 1-4
Beta 3.31
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.

BNTC News & Stock Updates